Follow on Google News News By Tag * Pharmaceutical Marketing Research * Pharmaceutical promotion research * Oncology Marketing Research * More Tags... Industry News * Pharmaceuticals * More Industries... News By Place Country(s) Industry News
Follow on Google News | IMPACTRX ACQUIRES TARGETRX Combined company to provide unparalleled insightImpactRx, a Symphony Technology Group (STG) company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced today that it has acquired 100% of TargetRx, Inc.
By: Patrick Angelastro “We are very excited to join forces with TargetRx,” declared Ellis. “In the years we spent in the marketplace together, and from the feedback we received from customers, it’s clear that the capabilities of these two companies are very complementary” Since its founding in 1999, TargetRx has served a majority of the top thirty pharmaceutical and biotech companies providing them insight into the drivers of product choice and the adoption of their brands. Powered by its unique AdvantageBuilder™ “When we acquired ImpactRx earlier this year, our strategic intent was to build a differentiated solutions company in life sciences capable of delivering compelling value to clients through insights informed by data,” said J.T. Treadwell, Managing Director with STG. “STG has a strong history of partnering with our companies to deliver innovation and growth, and we believe the addition of the TargetRx capabilities allows us to combine unique assets and complementary approaches, analytical talent, and a strong history of joint innovation as the foundation of a world-class solutions provider,” Treadwell stated. About ImpactRx ImpactRx is the leading provider of consultative and analytically- About Symphony Technology Group Symphony Technology Group (STG) is a strategic private equity firm with the mission of investing in and building great software and services companies. In addition to capital, STG provides transformation expertise to enable its portfolio companies to deliver maximum value to clients, to retain and attract the best talent, to drive growth through innovation, and to achieve best-in-class business performance. STG's current portfolio consists of fourteen global companies with combined revenue of $2.5 billion and 15,000 employees spread across North America, Europe and Asia. For more information, visit: www.symphonytg.com. End
Account Phone Number Disclaimer Report Abuse
|
|